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All the reactions were conducted in dry solvents under argon atmosphere unless otherwise 
stated. Dry solvents were freshly distilled under argon from an appropriate drying agent 
before use. Gold complexes and PtCl2 were purchased from Aldrich. Compounds 9,
1 (S,S)-Ru1,2 
(R,R,R)-Au13  and L-Shi catalyst4 are known and were synthesized according to the reported 
procedures. All other reagents used were bought from Aldrich, Alfa Aesar, TCI or Acros and 
used without further purification. The abbreviation “rt” refers to reactions carried out 
approximately at 23 °C. Reaction mixtures were stirred using Teflon-coated magnetic stirring 
bars. Reaction temperatures were maintained using Thermowatch-controlled silicone oil 
baths. Thin-layer chromatography (TLC) was performed on silica gel plates and components 
were visualized by observation under UV light, and/or by treating the plates with p-
anisaldehyde or cerium nitrate solutions, followed by heating. Flash chromatography was 
carried out on silica gel (40-63 µm) unless otherwise stated. Dryings were performed with 
anhydrous Na2SO4. Concentration refers to the removal of volatile solvents via distillation using 
a Büchi rotary evaporator followed by residual solvent removal under high vacuum. NMR 
spectra were recorded in CDCl3, at 300 MHz (Varian), 400 MHz (Varian) or 500 MHz (Bruker 
and Varian). Chemical shifts were reported in parts per million (δ) using the residual solvent 
signals (Methanol-d4: δH 3.31, δC 49.00; CDCl3: δH 7.26, δC 77.16) as the internal standards for 
the 1H and 13C NMR spectra and coupling constants (J) in Hz. Carbon types and structure 
assignments were determined from DEPT-NMR and two-dimensional experiments (HMQC and 
HMBC, COSY 1D-nOe and NOESY). NMR spectra were analyzed using MestreNova© NMR data 
processing software (www.mestrelab.com). The following abbreviations are used to indicate 
signal multiplicity: s, singlet; d, doublet; t, triplet; q, quartet; dd, double doublet; ddd, doublet 
of doublet of doublets; td, triple doublet; dt, doublet of triplets; ddt, doublet of doublet of 
triplets; dtd, doublet of triplet of doublets;  m, multiplet; br, broad. Mass spectra (ESI-MS) 
were acquired using IT-MS Bruker AmaZon SL at CIQUS and also using chemical ionization (CI) 
electron impact (EI), or electrospray ionization (ESI) at the CACTUS facility of the University of 
Santiago de Compostela. The reactions were monitored by TLC. Enantioselectivities were 
determined in an Agilent GC system 6890N with Chiraldex G-TA 30m x 0.25mm analytical 
columns. Optical rotations were measured by used a Jasco P-2000 polarimeter. 
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Synthesis of (-)-englerin A 
Dimethyl (E)-2-(3-methylpenta-2,4-dien-1-yl)malonate (7): 
 
A solution of dimethyl malonate (35.1 mL, 306.0 mmol, 3.0 eq.) in THF (60 mL) was added to 
an ice-cooled suspension of NaH (4.89 g, 60% in mineral oil, 122 mmol, 1.2 eq.) in THF (450 
mL). After stirring at 23 °C for 1 h, a solution of dienyl bromide 65 (16.4 g, 102.0 mmol, 1.0 eq.) 
was added at 0 °C. The reaction mixture was allowed to stir for 3 h at 23 °C, poured into water 
and extracted with EtOAc. The combined organic layers were dried over Na2SO4, filtered and 
concentrated, and the resulting crude product was purified by flash chromatography (SiO2, 5 to 
20% EtOAc/hexanes) to give the diester 7 as a colorless oil (19.1 g, 88% yield). Rf = 0.49 (30% 
Et2O/hexanes). 
1H NMR (300 MHz CDCl3) δ 6.33 (dd, J = 17.4, 10.7 Hz, 1H), 5.39 (t, J = 7.5 Hz, 
1H), 5.13 (d, J = 17.4 Hz, 1H), 4.98 (d, J = 10.7 Hz, 1H), 3.73 (s, 6H), 3.43 (t, J = 7.6 Hz, 1H), 2.75 
(t, J = 7.5 Hz, 2H), 1.77 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 169.34 (CO), 140.92 (CH), 136.79 (C), 
127.21 (CH), 112.00 (CH2), 52.54 (CH3), 51.53 (CH), 27.72 (CH2), 11.69 (CH3). LRMS (m/z, ESI): 
235.09 [M+Na]+, 185.05, 138.98, 105.04. HRMS-ESI Calculated for C11H16NaO4 [M+Na]
+: 
235.0941, found 235.0936. 
(E)-N-Methoxy-N,5-dimethylhepta-4,6-dienamide (8): 
 
A solution of 7 (15.0 g, 70.7 mmol, 1.0 eq.), NaCN (17.3 g, 353 mmol, 5.0 eq.), and water (6.37 
mL, 353 mmol, 5.0 eq.) in DMSO (707 mL) was stirred for 48 h at 80 °C. When the reaction was 
complete water (700 mL) was added, and the resulting mixture was extracted with pentane (3 
x 250 mL). The combined pentane fractions were washed with water and dried over Na2SO4, 
filtered and concentrated in vacuo to give ester 7a as a colorless oil (8.83 g, 81%) which was 
used without purification in the next step.   
MeNHOMe·HCl (11.13 g, 114 mmol, 2.0 eq.), followed by iPrMgCl (2.0 M in THF, 120 mL, 240 
mmol, 4.2 eq.) were added to a solution of the crude product 7a (8.80 g, 57.1 mmol, 1.0 eq.) in 
THF (500 mL) at −15 °C The resulting mixture was warmed to 0 °C and stirred for 3 h before 
NH4Cl (sat.) (50 mL) was added. The layers were separated and the aqueous layer was 
extracted with EtOAc (3× 100 mL). The combined organic layers were washed with brine (100 
mL), dried over Na2SO4 and concentrated in vacuo. The crude product was purified by flash 
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chromatography (SiO2, 20 to 60% EtOAc/hexanes) to give the Weinreb amide 8 as a pale 
yellow oil (9.93 g, 95%). 
Compound 7a:6 Rf = 0.58 (30% Et2O/hexanes). 
1H NMR (300 MHz CDCl3) δ 6.36 (dd, J = 17.4, 
10.7 Hz, 1H), 5.46 (t, J = 6.9 Hz, 1H), 5.12 (d, J = 17.4 Hz, 1H), 4.95 (d, J = 10.7 Hz, 1H), 3.65 (s, 
3H), 2.51 – 2.29 (m, 4H), 1.76 (s, 3H). ). 13C NMR (75 MHz, CDCl3) δ 173.8 (C), 141.8 (CH), 135.8 
(C), 131.3 (CH), 111.6 (CH2), 51.9 (CH3), 34.3 (CH2), 24.3 (CH2), 11.9 (CH3).  
Compound 8: Rf = 0.60 (50% EtOAc/hexanes). 
1H NMR (300 MHz CDCl3) δ 6.36 (dd, J = 17.3, 
10.5 Hz, 1H), 5.50 (t, J = 6.3 Hz, 1H), 5.10 (d, J = 17.3 Hz, 1H), 4.94 (d, J = 10.7 Hz, 1H), 3.67 (s, 
3H), 3.18 (s, 3H), 2.53 – 2.44 (m, 4H), 1.77 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 174.09 (C), 
141.47 (CH), 135.08 (C), 131.49 (CH), 111.15(CH2), 61.24 (CH3), 32.20 (CH3), 31.66 (CH2), 23.32 
(CH2), 11.57 (CH3). LRMS (m/z, ESI): 184.13 [M+H]
+, 159.12, 145.10. HRMS-ESI Calculated for 
C10H18NO2 [M+H]
+: 184.1332, found 184.1340. 
(E)-2,10-Dimethyl-3-((tetrahydro-2H-pyran-2-yl)oxy)dodeca-9,11-dien-4-yn-6-one (10): 
 
nBuLi (13.5 ml, 2.5M in hexanes, 33.7 mmol, 1.5 eq.) was slowly added (0.2 mL/min) to a 
solution of propargyl ether 9 (6.15 g, 33.7 mmol 1.5 eq.) in THF (225 mL) at −78 °C. The 
reaction was stirred 30 min at −78 °C and a solution of the Weinreb amide 8 (4.12 g, 22.5 
mmol, 1.0 eq.) in THF (25 mL) was added. The solution was warmed to −15 °C. After 1 h, 
consumption of starting material was observed by TLC, NH4Cl (sat.) was added and the 
resulting mixture was diluted with EtOAc and water. The aqueous layer was separated and 
extracted with EtOAc (3× 100 mL). The combined organic layers were washed with brine, dried 
over Na2SO4, filtered and concentrated in vacuo. Purification of the crude material by flash 
chromatography (SiO2, 1 to 20% EtOAc/hexanes) affords the diene-ynone 10 as a 1:1 mixture 
of diastereomers (6.78 g, 99% yield, pale yellow oil).7 Rf = 0.46 and 0.51 (30% Et2O/hexanes). 
1H 
NMR (300 MHz, CDCl3) δ 6.29 (dd, J = 17.4, 10.6 Hz, 1H), 5.39 (t, J = 7.4 Hz, 1H), 5.07 (d, J = 17.4 
Hz, 1H), 4.91 (d, J = 10.8 Hz, 1.5H), 4.75 – 4.64 (m, 0.5H), 4.32 (d, J = 6.1 Hz, 0.5H), 4.13 (d, J = 
5.9 Hz, 0.5H), 3.96 (td, J = 10.6, 9.8, 0.5H), 3.74 (td, J = 10.1, 9.0, 0.5H), 3.56 – 3.44 (m, 1H), 
2.61 (t, J = 7.4 Hz, 2H), 2.46 (q, J = 7.4 Hz, 2H), 2.08 – 1.88 (m, 1H), 1.87 – 1.75 (m, 1H), 1.71 (s, 
3H), 1.68 – 1.57 (m, 2H), 1.57 – 1.45 (m, 3H), 1.07 – 0.91 (m, 6H). 13C NMR (75 MHz, CDCl3) δ 
186.74 (C), 186.57(C), 141.10 (CH), 141.05 (CH), 135.40 (C), 135.32 (C), 130.07 (CH), 129.90 
(CH), 111.44 (CH2), 111.35 (CH2), 99.22 (CH), 95.65 (CH), 91.71 (C), 90.55 (C), 84.88 (C), 84.07 
(C), 72.86 (CH), 69.91 (CH), 62.16 (CH2), 62.00 (CH2), 45.23 (CH2), 45.17 (CH2), 33.03 (CH), 30.33 
(CH2), 30.30 (CH2), 25.43 (CH2), 22.80 (CH2), 19.09 (CH2), 18.76 (CH2), 18.60 (CH3), 18.28 (CH3), 
18.18 (CH3), 17.71 (CH3), 11.68 (CH3). LRMS-CI (m/z, I): 305 ([M+H]
+, 18), 221 (25), 203 (75), 
161 (63), 85 (100). HRMS-CI Calculated for C19H29O3 [M+H]
+: 305.2117, found 305.2109. 
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A solution of diene-ynone 10 (4.7 g, 15.44 mmol, 1.0 eq.) in iPrOH (25 mL) was added to a 
solution of (S,S)-Ru1 (231 mg, 0.386 mmol, 2.5 mol%) in iPrOH (125 mL) at 23 °C. After stirring 
the mixture for 1 h,  the volatiles were concentrated in vacuo, redissolved in ether and filtered 
over a Florisil® pad to give propargylic alcohol 11 as a colorless oil (4.73 g, quant.), which was 
subsequently used in the next step without further purification. A solution of crude product 11 
(4.73 g, 15.44 mmol, 1.0 eq.) in Et2O (125 mL) was added at 23 °C to a suspension of LiAlH4 
(1.45 g, 38.6 mmol, 2.5 eq.) in Et2O (25 mL). The mixture was warmed to 40 °C and, after 2 h, 
the reaction was cooled in an ice bath and cold water was added, stirred for 1 h, filtered over 
silica and concentrated in vacuo. Purification of the crude residue by flash chromatography 
(SiO2, 5 to 20% EtOAc/hexanes) afforded the allenediene 2a as a mixture of diastereomers 
(2.61 g, 82% yield, colorless oil).8  
Compound 11:8 Rf = 0.39 (30% Et2O/hexanes. 
1H NMR (300 MHz, CDCl3) δ 6.34 (dd, J = 17.4, 
10.7 Hz, 1H), 5.47 (t, J = 7.5 Hz, 1H), 5.08 (d, J = 17.4 Hz, 1H), 4.99 – 4.88 (m, 2H), 4.39 (t, J = 5.4 
Hz, 1H), 4.21 (d, J = 6.2 Hz, 1H), 3.78 (ddd, J = 11.5, 9.0, 3.2 Hz, 1H), 3.56 – 3.46 (m, 1H), 2.43 (s, 
1H), 2.30 (q, J = 7.7, 7.0 Hz, 2H), 2.05 – 1.82 (m, 1H), 1.82 – 1.70 (m, 7H), 1.63 – 1.47 (m, 4H), 
1.02 (d, J = 3.0 Hz, 3H), 1.00 (d, J = 3.1 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 141.41 (CH), 134.96 
(C), 131.67 (CH), 110.99 (CH2), 95.18 (CH), 87.23 (C), 82.75 (C), 70.28 (CH), 62.05 (CH2), 61.96 
(CH), 37.59 (CH2), 33.22 (CH), 30.51 (CH2), 25.59 (CH2), 24.11 (CH2), 19.19 (CH2), 18.76 (CH3), 
18.27 (CH3), 11.73 (CH3). LRMS-CI (m/z, I): 307 ([M+H]
+, 25), 204 (78), 177 (81), 135 (96), 121 
(98), 86 (100). 
Compound 2a: Rf = 0.57 (20% EtOAc/hexanes). 
1H NMR (300 MHz, CDCl3) δ 6.36 (dd, J = 17.4, 
10.7 Hz, 1H), 5.49 (t, J = 7.4 Hz, 1H), 5.39 – 5.20 (m, 2H), 5.07 (d, J = 17.3 Hz, 1H), 4.92 (d, J = 
10.7 Hz, 1H), 4.20 – 4.03 (m, 1H), 2.39 – 2.18 (m, 3H), 1.90 – 1.80 (m, 1H), 1.74 (s, 3H), 1.63 (td, 
J = 7.7, 6.1 Hz, 2H), 1.03 (d, J = 3.0 Hz, 3H), 1.00 (d, J = 3.0 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 
200.87 (C), 200.55 (C), 141.54 (CH), 134.55 (C), 132.38 (CH), 110.72 (CH2), 102.14 (CH), 101.65 
(CH), 96.92 (CH), 69.85 (CH), 69.28 (CH), 37.22 (CH2), 27.99 (CH), 24.42 (CH2), 24.32 (CH2), 
22.55 (CH3), 11.73 (CH3). LRMS (m/z, ESI): 207.17 [M+H]
+, 189.16, 145.10. HRMS-ESI Calculated 
for C14H23O [M+H]
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A solution of allenediene 2a (2.43 g, 11.78 mmol, 1.0 eq.) in CH2Cl2 (20 mL) was added to a 
solution of imidazole (3.21 g, 47.1 mmol, 4.0 eq.), DMAP (288 mg, 2.35 mmol, 20 mol%) and 
TBSCl (3.55 g, 23.55 mmol, 2.0 eq.) in CH2Cl2 (60 mL). The resulting reaction mixture was 
stirred for 1.5 h at 23 °C, water (10 mL) was added and the resulting mixture was extracted 
with CH2Cl2. The combined extracts were washed with brine (30 mL), dried over Na2SO4, 
filtered and concentrated in vacuo. The residue was purified by column chromatography (SiO2, 
5% Et2O/hexanes with 0.5% Et3N) to give allenediene 2b as a mixture of diastereomers (3.78 g, 
quant., colorless oil).9 Rf = 0.83 (20% Et2O/hexanes). 
1H NMR (300 MHz, CDCl3) δ 6.38 (dd, J = 
17.4, 10.7 Hz, 1H), 5.51 (t, J = 7.4 Hz, 1H), 5.24 – 5.13 (m, 2H), 5.09 (d, J = 17.3 Hz, 1H), 4.93 (d, 
J = 10.6 Hz, 1H), 4.21 – 4.09 (m, 1H), 2.39 – 2.11 (m, 3H), 1.75 (s, 3H), 1.70 – 1.57 (m, 2H), 1.03 
(t, J = 6.6 Hz, 6H), 0.91 (s, 9H), 0.08 (s, 6H). 13C NMR (75 MHz, CDCl3) δ 201.39 (C), 201.09 (C), 
141.72 (CH), 141.69 (CH), 134.26 (C), 133.00 (CH), 132.91 (CH), 110.50 (CH2), 100.24 (CH), 
99.69 (CH), 96.97 (CH), 72.26 (CH), 71.32 (CH), 38.71 (CH2), 38.54 (CH2), 28.40 (CH), 28.05 (CH), 
26.05 (CH3), 24.54 (CH2), 24.36 (CH2), 22.91 (CH3), 22.86 (CH3), 22.73 (CH3), 22.62 (CH3), 18.35 
(C), 11.78 (CH3), -4.00 (CH3), -4.69 (CH3). LRMS-CI: (m/z, I): 321 ([M+H]
+, 43), 305 (94), 263 (95), 
239 (92), 189 (90), 81 (100). LRMS (m/z, ESI): 321.26 [M+H]+, 189.16, 133.10, 105.06. HRMS-
ESI Calculated for C20H37OSi [M+H]




A solution of allenediene 2b (2.0 g, 6.24 mmol, 1.0 eq.) in o-xylene (10 mL) was added to a 
suspension of PtCl2 (83.0 mg, 0.312 mmol, 5 mol%) and tris(pentafluorophenyl)phosphine (166 
mg, 0.312 mmol, 5 mol%) in o-xylene (52 ml) which was previously heated at 150 °C. The 
mixture was stirred for 30 min and, after completion of the reaction (the progress of the 
process was monitored by TLC), allowed to cool down to 23 °C and filtered through a pad of 
Florisil®, eluting with Et2O. The filtrate was concentrated in vacuo and purified by flash 
chromatography (SiO2 15-40 µm, 0.1 to 5% Et2O/hexanes) to afford the cycloadduct 3b (1.42 g, 
71% yield, colorless oil) and the triene 12b (100 mg, 5% yield, yellow oil).  
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Compound 3b: Rf = 0.41 (1% Et2O/hexanes). [α]D
20.1= -24.39 (c 1.0, CHCl3). 
1H NMR (500 MHz, 
CDCl3) δ 5.50 (d, J = 4.8 Hz, 1H), 5.36 (ddt, J = 7.6, 3.9, 1.9 Hz, 1H), 3.97 (td, J = 8.7, 6.0 Hz, 1H), 
2.94 (d, J = 17.2 Hz, 1H), 2.52 – 2.42 (m, 2H), 2.22 – 2.09 (m, 2H), 1.94 (dtd, J = 12.9, 8.8, 7.2 Hz, 
1H), 1.87 – 1.79 (m, 1H), 1.62 (s, 3H), 1.61 – 1.56 (m, 1H), 1.56 – 1.46 (m, 1H), 0.98 (d, J = 6.7 
Hz, 6H), 0.90 (s, 9H), 0.074 (s, 3H), 0.068 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 147.45 (C), 
139.14 (C), 123.39 (CH), 120.86 (CH), 79.26 (CH), 50.56 (CH), 44.02 (CH), 36.36 (CH), 32.40 
(CH2), 29.85 (CH2), 27.79 (CH2), 26.11 (CH3), 23.10 (CH3), 21.56 (CH3), 21.30 (CH3), 18.38 (C), -
4.21 (CH3), -4.35 (CH3). LRMS-EI (m/z, I): 307 (M
+, 6), 263 (100), 187 (39), 145 (75), 75 (98). 
HRMS-EI Calculated for C20H36OSi [M]
+: 320.2535, found 320.2541. GC analysis on Chiraldex G-
TA 30m x 0.25mm showed a 99.1% enantiomeric excess. The relative stereochemistry of the 
3b was determined by nOe experiments (Figure 1). 
 
Racemic sample: 10 : 
 
 




Compound 12b: Rf = 0.50 (1% Et2O/hexanes). [α]D
21.5= +76.66 (c 0.97, CHCl3). 
1H NMR (400 
MHz, CDCl3) δ 6.66 (dd, J = 17.3, 10.8 Hz, 1H), 5.33 (dd, J = 15.1, 6.9 Hz, 1H), 5.19 (dd, J = 15.5, 
6.9 Hz, 1H), 5.03 (d, J = 17.9 Hz, 1H), 4.87 (d, J = 10.8 Hz, 1H), 3.98 (q, J = 3.7 Hz, 1H), 3.19 (d, J 
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eq.) to afford the racemic allenediene 2a (81% yield), which was subsequently protected with TBSCl and 
submitted to the cycloaddition process to yield 3b, as described above for the asymmetric version. 
S8 
 
= 7.1 Hz, 1H), 2.53 (dt, J = 17.0, 8.3 Hz, 1H), 2.40 – 2.27 (m, 1H), 2.27 – 2.19 (m, 1H), 1.85 – 1.80 
(m, 1H), 1.77 (s, 3H), 1.64 – 1.59 (m, 1H), 0.95 (s, 3H), 0.94 (s, 3H), 0.86 (s, 9H), 0.04 (s, 6H). 13C 
NMR (101 MHz, CDCl3) δ 143.56 (C), 138.44 (CH), 137.22 (CH), 127.56 (CH), 126.77 (C), 109.71 
(CH2), 79.75 (CH), 54.74 (CH), 32.60 (CH2), 31.06 (CH), 28.84 (CH2), 25.89 (CH3), 22.57 (CH3), 
18.17 (C), 14.45 (CH3), -4.56 (CH3), -4.59 (CH3). LRMS (m/z, ESI): 321.26 [M+H]
+, 261.18, 247.16, 
133.10, 105.07. HRMS-ESI Calculated for C20H37OSi [M+H]
+: 321.2608, found 321.2609. The 





A solution of cycloadduct 3b (564 mg, 1.76 mmol, 1.0 eq.) and N-methylmorpholine N-oxide 
(412 mg, 3.52 mmol, 2.0 eq.) in acetone (5 mL) was added to a solution of K2OsO4 (194 mg, 
0.528 mmol, 30 mol%) and methanesulfonamide (251 mg, 2.64 mmol, 1.5 eq.) in acetone (35 
mL) and water (4 mL) at 23 °C. The mixture was stirred for 12 h before Na2SO3 (sat.) (20 mL) 
was added, and the resulting mixture was stirred for additional 30 min. The volatile materials 
were concentrated in vacuo and the aqueous layer was extracted with EtOAc (3× 50 mL). The 
combined organic layers were washed with brine, dried over Na2SO4, filtered and concentrated 
in vacuo. Purification of the crude residue by flash chromatography (SiO2, 10 to 50% 
EtOAc/hexanes) afforded the diol 4b (455 mg, 73% yield, colorless foam) and its isomer 4b´ (12 
mg, 2% yield, pale brown foam).11  
Compound 4b: Rf = 0.46 (50% EtOAc/hexanes). [α]D
21.2 = +52.79 (c 0.99, CHCl3). 
1H NMR (500 
MHz, CDCl3) δ 5.63 (dt, J = 2.8, 1.3 Hz, 1H), 3.84 (td, J = 8.3, 6.5 Hz, 1H), 3.58 (t, J = 7.8 Hz, 1H), 
2.48 (ddd, J = 16.0, 8.5, 1.6 Hz, 1H), 2.28 (s, 1H), 2.25 (d, J = 1.5 Hz, 1H), 2.23 – 2.18 (m, 1H), 
2.02 – 1.94 (m, 1H), 1.93 – 1.77 (m, 3H), 1.68 (ddd, J = 12.2, 8.2, 4.1 Hz, 1H), 1.59 (s, 1H), 1.52 – 
1.45 (m, 1H), 1.23 (s, 3H), 1.01 (d, J = 4.8 Hz, 3H), 0.99 (d, J = 4.7 Hz, 3H), 0.90 (s, 9H), 0.08 (s, 
3H), 0.07 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 143.15 (C), 126.58 (CH), 79.81 (CH), 76.40 (C), 
75.29 (CH), 48.83 (CH), 45.60 (CH), 37.28 (CH), 33.68 (CH2), 33.19 (CH2), 26.18 (CH3), 22.11 
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(CH2), 21.78 (CH3), 21.61 (CH3), 19.24 (CH3), 18.42 (C), -4.02 (CH3), -4.29 (CH3). LRMS (m/z, ESI): 
377.24 [M+Na]+, 319.24, 245.07, 187.15. HRMS-ESI Calculated for C20H38NaO3Si [M+Na]
+: 
377.2482, found 377.2484. The relative stereochemistry of the 4b was determined by nOe 
experiments (Figure 3). 
 
Compound 4b´: Rf = 0.52 (50% EtOAc/hexanes). [α]D
21.3= -31.25 (c 0.94, CHCl3). 
1H NMR (300 
MHz, CDCl3) δ 5.58 (d, J = 3.4 Hz, 1H), 3.89 – 3.74 (m, 1H), 3.32 (t, J = 8.6 Hz, 1H), 2.71 (dd, J = 
15.0, 10.0 Hz, 1H), 2.47 – 2.33 (m, 1H), 2.32 (s, 1H), 2.20 (dt, J = 13.2, 6.6 Hz, 1H), 2.11 (t, J = 3.3 
Hz, 1H), 1.98 – 1.75 (m, 2H), 1.67 (s, 1H), 1.64 – 1.57 (m, 2H), 1.50 – 1.42 (m, 1H), 1.20 (s, 3H), 
1.00 (d, J = 1.4 Hz, 3H), 0.98 (s, 3H), 0.89 (s, 9H), 0.07 (s, 3H), 0.05 (s, 3H). 13C NMR (126 MHz, 
CDCl3) δ 143.65 (C), 126.79 (CH), 79.68 (CH), 75.35 (CH), 74.80 (C), 48.18 (CH), 46.31 (CH), 
36.67 (CH), 34.39 (CH2), 32.63 (CH2), 26.02 (CH3), 25.76 (CH3), 22.08 (CH2), 21.48 (CH3), 21.09 
(CH3), 18.26 (C), -4.18 (CH3), -4.44 (CH3). LRMS (m/z, ESI): 377.24 [M+Na]
+, 3190.24, 205.16, 
158.09. HRMS-ESI Calculated for C20H38NaO3Si [M+Na]
+: 377.2482, found 377.2481. The 
relative stereochemistry of the 4b´ was determined by nOe experiments (Figure 4). 
 
(1S,3aR,4S,5R,8aS)-1-((tert-Butyldimethylsilyl)oxy)-4-hydroxy-7-isopropyl-4-methyl-
1,2,3,3a,4,5,6,8a-octahydroazulen-5-yl pivalate (13b): 
 
Et3N (5.0 mL, 35.8 mmol, 10.0 eq.), pivaloyl chloride (1.32 mL, 10.74 mmol, 3.0 eq.) and DMAP 
(88 mg, 0.72 mmol, 20 mol%) were successively added to a solution of diol 4b (1.27 g, 3.58 
mmol, 1.0 eq.) in CHCl3 (120 mL) at 0 °C. The resulting mixture was warmed to 65 °C and 
stirred for 12 h. After completion of the reaction, the mixture allowed to cool down to 23 °C 
and it was directly absorbed in silica, concentrated in vacuo and purified by flash 
chromatography (SiO2, 2.5 to 30% EtOAc/hexanes with 5% CH2Cl2) to afford 13b (1.56 g, 99% 
yield, pale brown oil). Rf = 0.60 (50% EtOAc/hexanes). [α]D




(500 MHz, CDCl3) δ 5.54 (d, J = 2.2 Hz, 1H), 4.72 (dd, J = 9.3, 1.2 Hz, 1H), 3.80 (q, J = 7.6 Hz, 1H), 
2.63 (ddd, J = 17.4, 9.2, 1.7 Hz, 1H), 2.10 (p, J = 7.7, 7.1 Hz, 1H), 2.05 – 1.97 (m, 3H), 1.91 – 1.73 
(m, 2H), 1.74 – 1.61 (m, 1H), 1.53 – 1.42 (m, 1H), 1.27 – 1.23 (m, 1H), 1.22 (s, 3H), 1.21 (s, 9H), 
0.96 (d, J = 6.8 Hz, 3H), 0.94 (d, J = 6.7 Hz, 3H), 0.89 (s, 9H), 0.08 (s, 3H), 0.06 (s, 3H). 13C NMR 
(126 MHz, CDCl3) δ 177.68 (CO), 143.32 (C), 124.68 (CH), 79.66 (CH), 77.74 (CH), 75.75 (C), 
48.91 (CH), 45.79 (CH), 39.20 (C), 37.02 (CH), 33.65 (CH2), 30.84 (CH2), 27.42 (CH3), 27.14 (CH3), 
26.01 (CH3), 22.00 (CH2), 21.49 (CH3), 19.84 (CH3), 18.24 (C), -4.20 (CH3), -4.45 (CH3). LRMS 
(m/z, ESI): 461.30 [M+Na]+, 347.22, 319.24, 187.14. HRMS-ESI Calculated for C25H46NaO4Si 
[M+Na]+: 461.3058, found 461.3059. 
(1S,3aR,4S,5R,8aS)-1,4-Dihydroxy-7-isopropyl-4-methyl-1,2,3,3a,4,5,6,8a-octahydroazulen-5-
yl pivalate (13): 
 
HF·Py (2.78 mL, ~70% in pyridine, 21.65 mmol, 10.0 eq.) was added dropwise to a solution of 
the silyl ether 13b (950 mg, 2.165 mmol, 1.0 eq.) in THF (10 mL) in a falcon type tube (50 mL). 
The mixture was stirred for 4 h at 23 °C. After completion of the reaction, the mixture was 
cooled at 0 °C and Na2CO3 (sat.) (20 mL) was added. The aqueous layer was separated and 
extracted with EtOAc (3× 30 mL). The combined organic layers were washed with brine, dried 
over Na2SO4, filtered and concentrated in vacuo. Purification of the crude residue by flash 
chromatography (SiO2, 20 to 50% EtOAc/hexanes with 10% CH2Cl2) afforded the alcohol 13 as a 
white foam (630 mg, 90% yield). Rf = 0.48 (50% EtOAc/hexanes). [α]D
19.9 = -1.29 (c 1.0, CHCl3). 
1H NMR (500 MHz, CDCl3) δ 5.59 (s, 1H), 4.73 (dd, J = 9.0, 1.2 Hz, 1H), 3.92 (q, J = 7.2 Hz, 1H), 
2.61 (ddd, J = 16.4, 9.0, 1.6 Hz, 1H), 2.11 (p, J = 6.8 Hz, 1H), 2.07 – 2.01 (m, 3H), 1.99 – 1.87 (m, 
3H), 1.87 – 1.76 (m, 1H), 1.73 (dt, J = 13.6, 6.7 Hz, 1H), 1.52 (ddt, J = 12.5, 9.3, 7.2 Hz, 1H), 1.22 
(s, 3H), 1.20 (s, 9H), 0.97 (d, J = 6.8 Hz, 3H), 0.93 (d, J = 6.8 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 
177.87 (CO), 144.20 (C), 124.58 (CH), 79.67 (CH), 77.60 (CH), 75.73 (C), 49.21 (CH), 47.14 (CH), 
39.32 (C), 37.21 (CH), 33.80 (CH2), 30.65 (CH2), 27.52 (CH3), 22.61 (CH2), 21.52 (CH3), 21.42 
(CH3), 19.93 (CH3). LRMS (m/z, ESI): 347.22 [M+Na]
+, 236.07, 205.16, 187.15. HRMS-ESI 
Calculated for C19H32NaO4 [M+Na]
+: 347.2193, found 347.2198. 
(1S,3aR,4S,5R,7R,8S,8aS)-1,8-Dihydroxy-7-isopropyl-4-methyldecahydro-4,7-epoxyazulen-5-




Method A (Table 2, entry 4): mCPBA (85 mg, 0.370 mmol, 1.2 eq.) was added to a solution of 
alcohol 13 (100 mg, 0.308 mmol, 1.0 eq.) in CHCl3 (10 mL) at 23 °C and warmed to 55 °C for 5 h. 
After completion of the reaction, the mixture was allowed to cool to 23 °C and NaHCO3 (sat.) 
(10 mL) was added. The aqueous layer was separated and extracted with CH2Cl2 (3× 10 mL). 
The combined organic layers were dried over Na2SO4, filtered and concentrated in vacuo to 
give a crude residue which was purified by flash chromatography (SiO2 15-40 µm, 10 to 70% 
EtOAc/hexanes with 10% CH2Cl2) to give the oxatryciclic compound 5a (52 mg, 50% yield, white 
foam) and the epoxide 14´ (52 mg, 50% yield, amorphous solid). 
Method B (Table 2, entry 5): MMPP (2.05 g, 4.13 mmol, 1.5 eq.) was added to a solution of 
alcohol 13 (894 mg, 2.76 mmol, 1.0 eq.) in CH3CN (92 mL). The suspension was stirred for 4 h at 
85 °C, cooled down to 23 °C, filtered and concentrated in vacuo.  The white solid residue was 
dissolved in EtOAc, and the resulting organic phase was washed with Na2SO3 (10%), NaHCO3 
(sat.), and water, dried over Na2SO4, filtered and concentrated in vacuo. Purification of the 
crude was carried out as for Method A, to give 5a (470 mg, 50% yield) and 14´ (468 mg, 50% 
yield). 
Method C (Table 2, entry 7): Alcohol 13 (440 mg, 1.36 mmol, 1.0 eq.) was dissolved in CH3CN 
(6.5 mL) and dimethoxymethane (DMM) (13 mL). Then, a Borax buffer solution [20 mL, 0.05 M 
solution of Na2B4O7·10H2O in 4×10
-4 M aqueous Na2(EDTA)], (
nBu)4NHSO4 (0.015 g, 0.04 mmol), 
and L-Shi catalyst (105 mg, 0.407 mmol, 30 mol%) were subsequently added. A solution of 
Oxone® (2.5 g, 4.07 mmol, 3.0 eq) in aqueous Na2(EDTA) (12 mL, 4×10
-4 M) and a solution of 
K2CO3 (1.31 g, 9.49 mmol, 7.0 eq.) in water (12 mL) were added dropwise separately over a 
period of 1.5 h. The mixture was stirred at 23 °C for 12 h, diluted with water (50 mL), and 
extracted with EtOAc (4 × 50 mL). The combined extracts were washed with brine, dried over 
Na2SO4, filtered and concentrated in vacuo. The crude was redissolved in CH3CN (20 mL) and 
warmed at 85 °C for 2 h. Then, the reaction mixture was cooled down to 23 °C, absorbed in 
silica, and evaporated under vacuo. Purification of the crude residue was carried out as for 
Method A, to give 5a (328 mg, 71% yield) and 14´ (73 mg, 16% yield). 
Compound 5a: Rf = 0.28 (50% EtOAc/hexanes). [α]D
18.8 = -2.69 (c 0.93, CHCl3). 
1H NMR (500 
MHz, CDCl3) δ  5.02 (dd, J = 7.8, 2.8 Hz, 1H), 4.07 (td, J = 8.9, 5.7 Hz, 1H), 3.69 (d, J = 9.1 Hz, 1H), 
2.51 (dd, J = 14.5, 7.8 Hz, 1H), 2.47 (brs, 2H), 2.18 – 2.06 (m, 1H), 1.97 (hept, J = 7.0 Hz, 1H), 
1.67 – 1.58 (m, 2H), 1.57 – 1.47 (m, 2H), 1.47 – 1.40 (m, 1H), 1.39 – 1.30 (m, 1H), 1.21 (s, 9H), 
1.13 (s, 3H), 1.04 (d, J = 7.1 Hz, 3H), 1.03 (d, J = 7.0 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 178.20 
(CO), 86.09 (C), 84.39 (C), 77.07 (CH), 74.91 (CH), 74.49 (CH), 51.43 (CH), 48.22 (CH), 39.04 
(CH2), 38.99 (C), 32.23 (CH2), 31.54 (CH), 27.27 (CH3), 23.54 (CH2), 18.46 (CH3), 18.16 (CH3), 
17.17 (CH3). LRMS (m/z, ESI): 341.23 [M+H]
+, 239.16, 221.15, 203.14.  HRMS-ESI Calculated for 
C19H33O5 [M+H]
+: 41.2323, found 341.2320. The relative stereochemistry of the 5a was 




Compound 14´: Rf = 0.39 (50% EtOAc/hexanes). [α]D
21.6= +37.11 (c 1.01, CHCl3). 
1H NMR (500 
MHz, CDCl3) δ 4.60 (dd, J = 10.6, 1.3 Hz, 1H), 4.15 (q, J = 6.5 Hz, 1H), 3.11 (d, J = 1.0 Hz, 1H), 
2.30 (dd, J = 15.6, 10.6 Hz, 1H), 2.05 (dt, J = 11.5, 8.6 Hz, 1H), 1.93 – 1.85 (m, 3H), 1.80 – 1.71 
(m, 2H), 1.64 (dd, J = 15.6, 1.4 Hz, 1H), 1.57 (ddd, J = 12.5, 8.6, 6.3 Hz, 1H), 1.48 (p, J = 6.9 Hz, 
1H), 1.24 (s, 9H), 1.11 (s, 3H), 0.96 (d, J = 5.3 Hz, 3H), 0.95 (d, J = 5.0 Hz, 3H). 13C NMR (126 
MHz, CDCl3) δ 177.46 (CO), 77.02 (CH), 76.75 (CH), 74.68 (C), 65.70 (C), 61.82 (CH), 48.91 (CH), 
40.67 (CH), 39.30 (C), 37.52 (CH), 34.76 (CH2), 28.61 (CH2), 27.46 (CH3), 22.76 (CH2), 20.24 
(CH3), 18.10 (CH3), 17.28 (CH3). LRMS (m/z, ESI): 363.21 [M+Na]
+, 277.11, 236. HRMS-ESI 
Calculated for C19H32NaO5 [M+Na]
+: 363.2142, found 363.2151. The relative stereochemistry of 
the 14´ was determined by nOe experiments (Figure 6). 
 
(1S,3aR,4S,5R,7R,8S,8aR)-8-Hydroxy-7-isopropyl-4-methyl-1-(tosyloxy)decahydro-4,7-epoxy-
azulen-5-yl pivalate (15): 
 
p-Toluenesulfonyl chloride (248 mg, 1.30 mmol, 1.5 eq.) and Et3N (181 µL, 1.30 mmol, 1.5 eq.) 
were added to a solution of the diol 5a (295 mg, 0.866 mmol, 1.0 eq.) in CH2Cl2 (4 mL). The 
mixture was cooled in an ice-water bath and DMAP (2.65 mg, 2.17 mmol, 2.5 eq.) was added. 
After 10 min the ice bath was removed and stirring was continued at 23 °C for additional 12 h. 
The mixture was poured into NaHSO4 (30% aq.) and the organic phase was separated and 
washed with water and brine, dried over Na2SO4, filtered and concentrated in vacuo. 
Purification of the crude residue by flash chromatography (SiO2, 5 to 30% EtOAc/hexanes with 
5% CH2Cl2) afforded 15 (407 mg, 95% yield, white foam). 
Rf = 0.61 (50% EtOAc/hexanes). [α]D
20.2= -24.41 (c 1.0, CHCl3). 
1H NMR (500 MHz, CDCl3) δ 7.79 
(d, J = 8.3 Hz, 2H), 7.34 (d, J = 8.0 Hz, 2H), 4.98 (dd, J = 7.9, 2.8 Hz, 1H), 4.73 (td, J = 9.1, 5.7 Hz, 
1H), 3.68 (d, J = 9.4 Hz, 1H), 2.78 (brs, 1H), 2.50 (dd, J = 14.6, 7.9 Hz, 1H), 2.44 (s, 3H), 2.06 – 
1.90 (m, 2H), 1.74 – 1.61 (m, 3H), 1.61 – 1.53 (m, 1H), 1.51 – 1.41 (m, 1H), 1.38 (td, J = 12.8, 6.1 
Hz, 1H), 1.19 (s, 9H), 1.10 (s, 3H), 1.03 (d, J = 7.0 Hz, 3H), 1.00 (d, J = 6.8 Hz, 3H).  13C NMR (126 
MHz, CDCl3) δ 177.99 (CO), 145.27 (C), 133.33 (C), 130.04 (CH), 127.94 (CH), 86.08 (C), 84.13 
(CH), 83.85 (C), 74.54 (CH), 72.85 (CH), 50.31 (CH), 48.02 (CH), 38.92 (C), 38.86 (CH2), 31.42 
(CH), 29.61 (CH2), 27.23 (CH3), 23.31 (CH2), 21.78 (CH3), 18.43 (CH3), 18.02 (CH3), 16.99 (CH3). 
LRMS (m/z, ESI): 495.24 [M+H]+, 477.23, 375.16, 323.21. HRMS-ESI Calculated for C26H39O7S 







MeLi (2.0 mL, 1.6 M, 3.24 mmol, 20.0 eq.) was added dropwise to a stirred suspension of 
CuBr·SMe2 (332 mg, 1.62 mmol, 10.0 eq.) in Et2O (3.0 mL) at −15 °C. After being stirred for 30 
min, a solution of the tosylate 15 (80.0 mg, 0.162 mmoles, 1.0 eq.) in Et2O (3.0 mL) was added 
dropwise. The resultant suspension was stirred at 23 °C for 2 h, cooled down to 0 °C and MeLi 
(1.0 mL, 1.6 M, 1.62 mmol, 10.0 eq.) was added dropwise. The resulting mixture was stirred for 
an additional hour, cooled in an ice-water bath and water (2 mL) was added, followed by NH4Cl 
(sat.). Extraction with EtOAc (3× 20 mL) provided an organic phase which was dried over 
Na2SO4, filtered, concentrated in vacuo and purified by flash chromatography (SiO2 15-40 µm, 
20 to 50% EtOAc/hexanes with 10% CH2Cl2) to afford the diol 19 (31.3 mg, 76% yield, white 
solid) and the alkene 18 (3.5 mg, 9% yield, white solid). 
Compound 19: Rf = 0.39 (50% EtOAc/hexanes). [α]D
19.2= -53.71 (c 1.0, CHCl3). 
1H NMR (500 
MHz, CDCl3) δ 3.93 (dd, J = 7.6, 2.5 Hz, 1H), 3.63 (d, J = 10.2 Hz, 1H), 2.46 (dd, J = 14.5, 7.6 Hz, 
1H), 2.30 (ddd, J = 15.5, 7.1, 2.7 Hz, 1H), 2.05 – 1.92 (m, 2H), 1.72 – 1.64 (m, 1H), 1.62 – 1.54 
(m, 2H), 1.25 (brs, 2H), 1.23 (s, 3H), 1.23 – 1.16 (m, 2H), 1.13 – 1.06 (m, 1H), 1.06 (d, J = 6.9 Hz, 
6H), 0.89 (d, J = 7.2 Hz, 3H).  13C NMR (126 MHz, CDCl3) δ 85.62 (C), 85.26 (C), 73.43 (CH), 70.97 
(CH), 47.96 (CH), 47.86 (CH), 41.93 (CH2), 32.13 (CH), 31.53 (CH2), 30.61 (CH), 25.94 (CH2), 
19.39 (CH3), 18.38 (CH3), 17.57 (CH3), 17.09 (CH3). LRMS (m/z, ESI): 277.12 [M+Na]
+, 237.18, 
201.16.   HRMS-ESI Calculated for C15H26NaO3 [M+Na]
+: 277.1774, found 277.1772. The relative 
stereochemistry of the compound 19 was determined by nOe experiments (Figure 7). 
 
Compound 18: Rf = 0.36 (50% EtOAc/hexanes). [α]D
22.3= -144.26 (c 0.64, CHCl3). 
1H NMR (300 
MHz, CDCl3) δ 6.10 (dt, J = 5.9, 1.3 Hz, 1H), 5.84 (ddd, J = 5.9, 4.4, 2.9 Hz, 1H), 4.20 – 4.02 (m, 
1H), 3.61 (dd, J = 10.6, 3.6 Hz, 1H), 2.53 (dd, J = 14.6, 7.4 Hz, 1H), 2.23 (dddd, J = 14.2, 6.1, 3.1, 
0.7 Hz, 1H), 2.17 – 2.03 (m, 1H), 1.99 (p, J = 7.0 Hz, 1H), 1.95 – 1.77 (m, 1H), 1.74 (dd, J = 12.3, 
6.1 Hz, 1H), 1.64 (dd, J = 14.6, 2.6 Hz, 1H), 1.58 (brs, 1H), 1.50 – 1.39 (m, 1H), 1.25 (s, 3H), 1.06 
(dd, J = 6.9, 1.1 Hz, 6H). 13C NMR (75 MHz, CDCl3) 132.72 (CH), 131.96 (CH), 86.54 (C), 84.52 (C), 
74.28 (CH), 72.64 (CH), 55.01 (CH), 49.37 (CH), 42.10 (CH2), 32.49 (CH2), 31.84 (CH), 18.76 
                                                          
12
 Compound 19 has been previously reported, see: a) H. Kusama, A. Tazawa, K. Ishida, N. Iwasawa, Chem. 
Asian J. 2016, 11, 64; b) J. Wang, S. G. Chen, B. F. Sun, G. Q. Lin, Y. J. Shang, Chem. Eur. J. 2013, 19, 2539. 
S14 
 
(CH3), 18.41 (CH3), 17.40 (CH3). LRMS (m/z, ESI): 239.23 [M+H]
+, 221.15, 141.02. LRMS (m/z, 




yl 2-((4-methoxybenzyl)oxy)acetate (25): 13 
 
EDCI (31.7 mg, 0.165 mmol, 2.0 eq.) was added to a solution of the diol 19 (21.0 mg, 0.083 
mmol, 1.0 eq.), 2-(4-methoxybenzyloxy)acetic acid (17.8 mg, 0.091 mmol, 1.1 eq.) and DMAP 
(2.0 mg, 0.017 mmol, 20 mol%) in CH2Cl2 (1.0 mL) at 0 °C. After stirring at 23 °C for 1 h, water 
(2.0 mL) was added, and the mixture was partitioned between EtOAc (30 mL) and water (5 
mL). The organic layer was washed with NH4Cl (sat.) (5 mL), water (5 mL) and brine (5 mL), and 
dried over anhydrous Na2SO4, filtered, concentrated in vacuo. The resulting crude residue was 
purified by flash chromatography (SiO2, 5 to 30% EtOAc/hexanes) to afford 25 (28.9 mg, 83% 
yield) as a colorless oil. 
Rf = 0.61 (50% EtOAc/hexanes). [α]D
23.1= -30.31 (c 0.92, CHCl3). 
1H NMR (300 MHz, CDCl3) δ 7.29 
(d, J = 8.2 Hz, 2H), 6.88 (d, J = 8.3 Hz, 2H), 5.12 (dd, J = 7.9, 2.9 Hz, 1H), 4.57 (s, 2H), 4.08 (s, 2H), 
3.80 (s, 3H), 3.65 (d, J = 10.1 Hz, 1H), 2.46 (dd, J = 14.5, 7.9 Hz, 1H), 2.38 – 2.25 (m, 1H), 2.10 – 
1.88 (m, 2H), 1.77 – 1.60 (m, 2H), 1.57 (dd, J = 12.7, 7.1 Hz, 1H), 1.37 (brs, 1H), 1.32 (dt, J = 
10.2, 3.1 Hz, 1H), 1.27 – 1.18 (m, 2H), 1.16 (s, 3H), 1.05 (dd, J = 6.9, 2.8 Hz, 6H), 0.89 (d, J = 7.1 
Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 170.33 (CO), 159.63 (C), 129.88 (CH), 129.29 (C), 114.03 
(CH), 86.05 (C), 84.52 (C), 75.81 (CH), 73.12 (CH2), 70.75 (CH), 66.95 (CH2), 55.42 (CH3), 48.10 
(CH), 48.04 (CH), 38.70 (CH2), 32.25 (CH), 31.42 (CH2), 30.65 (CH), 25.65 (CH2), 19.17 (CH3), 
18.41 (CH3), 17.53 (CH3), 16.99 (CH3). LRMS (m/z, ESI): 455.24 [M+Na]
+, 403.22, 373.25, 219.05. 
HRMS-ESI Calculated for C25H36NaO6 [M+Na]
+: 455.2404, found 455.2403. 
(-)-englerin A (1):  
 
2,4,6-trichlorobenzoyl chloride (30 µL, 0.194 mmol, 3.0 eq.) was added to a solution of (E)-
cinnamic acid (28.8 mg, 0.194 mmol, 3.0 eq.) and Et3N (54 µL, 0.388 mmol, 6.0 eq.) in toluene 
(0.5 mL) at 0 °C and the resulting mixture was stirred at 23 °C for 2 h. Then, a solution of 
                                                          
13
 Compound 25 has been previously reported, see: T. Hanari, N. Shimada, Y. Kurosaki, N. Thrimurtulu, H. 
Nambu, M. Anada, S. Hashimoto, Chem. Eur. J. 2015, 21, 11671. 
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compound 25 (28.0 mg, 0.065 mmol, 1.0 eq.) in toluene (0.5 mL) was added followed by 
addition of DMAP (47.4 mg, 0.388 mmol) and the mixture was stirred at 80 °C for 30 min. After 
completion of the reaction, NaHCO3 (sat.) was added, and the mixture was partitioned 
between EtOAc (30 mL) and water (5 mL). The organic layer was washed with NH4Cl (sat.) (5 
mL), water (5 mL) and brine (5 mL), and dried over anhydrous Na2SO4, filtered and 
concentrated in vacuo. The resulting crude mixture was purified by flash chromatography 
(SiO2, 5 to 20% EtOAc/hexanes) to afford the corresponding diester 26 (36.4 mg, 100%) as a 
colorless oil. Rf = 0.40 (20% EtOAc/hexanes). [α]D
24.4= -40.62 (c 0.81, CHCl3). 
1H NMR (400 MHz, 
CDCl3) δ 7.66 (d, J = 16.0 Hz, 1H), 7.53 (dd, J = 6.7, 3.0 Hz, 2H), 7.43 – 7.34 (m, 3H), 7.31 (d, J = 
8.6 Hz, 2H), 6.89 (d, J = 8.6 Hz, 2H), 6.39 (d, J = 15.9 Hz, 1H), 5.20 (dd, J = 7.9, 3.0 Hz, 1H), 5.13 
(d, J = 10.2 Hz, 1H), 4.59 (s, 2H), 4.10 (s, 2H), 3.81 (s, 3H), 2.67 (dd, J = 14.5, 7.9 Hz, 1H), 2.14 (h, 
J = 7.1 Hz, 1H), 2.02 – 1.93 (m, 1H), 1.89 (p, J = 7.1 Hz, 1H), 1.83 – 1.67 (m, 3H), 1.58 – 1.51 (m, 
1H), 1.35 – 1.23 (m, 2H), 1.21 (s, 3H), 1.01 (d, J = 6.8 Hz, 3H), 0.95 (dd, J = 9.4, 7.1 Hz, 6H). 13C 
NMR (101 MHz, CDCl3) δ 170.21 (CO), 165.56 (CO), 159.49 (C), 145.10 (CH), 134.24 (C), 130.35 
(CH), 129.71 (CH), 129.07 (C), 128.86 (CH), 128.08 (CH), 117.97 (CH), 113.86 (CH), 85.43 (C), 
84.49 (C), 75.52 (CH), 72.98 (CH2), 71.19 (CH), 66.78 (CH2), 55.25 (CH3), 47.49 (CH), 46.89 (CH), 
39.92 (CH2), 32.95 (CH), 31.16 (CH), 30.92 (CH2), 24.55 (CH2), 19.02 (CH3), 18.18 (CH3), 17.44 
(CH3), 16.87 (CH3). LRMS (m/z, ESI): 585.28 [M+Na]
+, 437.23, 389.20, 219.06. HRMS-ESI 
Calculated for C34H42NaO7 [M+Na]
+: 585.2823, found 585.2815. 
DDQ (40.7 mg, 0.179 mmol, 5.0 eq.) was added to a solution of diester 26 (20.2 mg, 0.036 
mmol, 1.0 eq.) in CH2Cl2 (0.38 mL) and water (19 µL) at 0 °C, and the mixture was stirred at 23 
°C for 7 h. After completion of the reaction, NaHCO3 (sat.) (2 mL) was added and the mixture 
was partitioned between EtOAc (40 mL) and water (5 mL). The organic layer was washed with 
NaHCO3 (sat.) (5 mL), water (5 mL) and brine (5 mL), and dried over anhydrous Na2SO4, filtered 
and concentrated in vacuo. The resulting crude residue was purified by flash chromatography 
(SiO2, 10 to 20% EtOAc/hexanes) to afford (-)-englerin A (15.9 mg, 100%) as a white 
amorphous solid. 
Rf = 0.36 (20% EtOAc/hexanes). [α]D
18.6= -47.86 (c 0.21, MeOH). 1H NMR (500 MHz, CD3OD) δ 
7.69 (d, J = 16.0 Hz, 1H), 7.64 – 7.57 (m, 2H), 7.43 – 7.37 (m, 3H), 6.51 (d, J = 16.0 Hz, 1H), 5.26 
(dd, J = 8.0, 3.0 Hz, 1H), 5.12 (d, J = 10.1 Hz, 1H), 4.15 (s, 2H), 2.70 (dd, J = 14.5, 8.0 Hz, 1H), 
2.13 (h, J = 7.0 Hz, 1H), 2.03 – 1.95 (m, 1H), 1.91 – 1.81 (m, 2H), 1.79 – 1.72 (m, 2H), 1.70 – 1.65 
(m, 1H), 1.35 – 1.24 (m, 3H), 1.19 (s, 3H), 1.01 (d, J = 6.8 Hz, 3H), 0.96 (d, J = 7.1 Hz, 3H), 0.93 
(d, J = 7.1 Hz, 3H).  13C NMR (126 MHz, CD3OD) δ 173.96 (CO), 167.31 (CO), 146.78 (CH), 135.65 
(C), 131.64 (CH), 130.06 (CH), 129.33 (CH), 118.79 (CH), 86.67 (C), 86.05 (C), 76.63 (CH), 72.45 
(CH), 61.03 (CH2), 48.91 (CH), 48.01 (CH), 40.71 (CH2), 34.09 (CH), 32.46 (CH), 32.00 (CH2), 
25.52 (CH2), 19.24 (CH3), 18.58 (CH3), 17.74 (CH3), 17.24 (CH3). LRMS (m/z, ESI): 465.22 
[M+Na]+, 443.23 [M+H]+, 425.23, 219.16.  HRMS-ESI Calculated for C26H34NaO6 [M+Na]
+: 




NMR (Methanol-d4, 500 MHz) data for natural and synthetic (-)-englerin A 
δH (m, J (Hz), xH)  δC 
Natural Synthetic ∆  Natural Synthetic Δ 
7.68 (d, 16.0, 1H) 7.69 (d, 16.0, 1H) 0.01  173.94 173.96 0.02 
7.61 (m, 2H) 7.61 (m, 2H) 0.00  167.26 167.31 0.05 
7.40 (brdd, 3.5, 3.0, 3H) 7.41 (m, 3H) 0.01  146.75 146.78 0.03 
6.50 (d, 16.0, 1H) 6.51 (d, 16.0, 1H) 0.01  135.62 135.65 0.03 
5.23 (dd, 8.0, 2.5, 1H) 5.26 (dd, 8.0, 3.0, 1H) 0.03  131.64 131.64 0.00 
5.10 (d, 10.0, 1H) 5.12 (d, 10.1, 1H) 0.02  130.06 130.06 0.00 
4.14 (brs, 2H) 4.15 (s, 2H) 0.01  129.33 129.33 0.00 
2.67 (dd, 14.0, 8.0, 1H) 2.70 (dd, 14.5, 8.0, 1H) 0.03  118.80 118.79 -0.01 
2.12 (m, 1H) 2.13 (m, 1H) 0.01  86.44 86.67 0.23 
1.98 (m, 1H) 2.00 (m, 1H) 0.02  86.01 86.05 0.04 
1.86 (dd, 14.0, 2.5, 1H) 1.86 (m, 2H) 0.00  76.61 76.63 0.02 
1.86 (m, 1H) - -  72.43 72.45 0.02 
1.73 (m, 1H) 1.75 (m, 2H) 0.02  61.03 61.03 0.00 
1.71 (m, 1H) - -  48.89 48.91 0.02 
1.63 (m, 1H) 1.68 (m, 1H) 0.05  47.99 48.01 0.02 
1.30 (m, 2H) 1.30 (m, 2H) 0.00  40.69 40.71 0.02 
1.18 (s, 3H) 1.19 (s, 3H) 0.01  34.04 34.09 0.05 
1.00 (d, 7.0, 3H) 1.01 (d, 6.8, 3H) 0.01  32.43 32.46 0.03 
0.95 (d, 7.0, 3H) 0.96 (d, 7.1, 3H) 0.01  31.99 32.00 0.01 
0.92 (d, 7.0, 3H) 0.93 (d, 7.1, 3H) 0.01  25.52 25.52 0.00 
    19.25 19.24 -0.01 
    18.59 18.58 -0.01 
    17.77 17.74 -0.03 




Synthesis of (-)-englerin A analogues 





39% yield (unoptimized). Rf = 0.37 (20% EtOAc/hexanes). [α]D
22.3= -22.30 (c 
0.91, CHCl3). 
1H NMR (300 MHz, CDCl3) δ 3.92 (dd, J = 7.6, 2.5 Hz, 1H), 3.67 (d, 
J = 10.2 Hz, 1H), 2.45 (dd, J = 14.5, 7.6 Hz, 1H), 2.15 – 2.03 (m, 1H), 1.98 (dt, J 
= 13.8, 6.9 Hz, 1H), 1.92 – 1.79 (m, 1H), 1.73 – 1.63 (m, 1H), 1.63 – 1.58 (m, 
1H), 1.58 – 1.49 (m, 2H), 1.49 – 1.39 (m, 3H), 1.39 – 1.24 (m, 6H), 1.21 (s, 3H), 
1.06 (d, J = 6.9 Hz, 6H), 1.02 – 0.94 (m, 1H), 0.89 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 
85.65 (C), 85.27 (C), 73.36 (CH), 70.85 (CH), 48.76 (CH), 48.05 (CH), 41.90 (CH2), 36.45 (CH), 
32.12 (CH), 30.67 (CH2), 30.17 (CH2), 28.84 (CH2), 26.11 (CH2), 23.15 (CH2), 19.39 (CH3), 18.39 
(CH3), 17.57 (CH3), 14.33 (CH3). LRMS (m/z, ESI): 319.22 [M+Na]
+, 290.15, 282.27, 261.22, 
243.21. HRMS-ESI Calculated for C18H32NaO3 [M+Na]




41% yield (unoptimized). Rf = 0.41 (50% EtOAc/hexanes). [α]D
21.6= -58.21 (c 
0.99, CHCl3). 
1H NMR (400 MHz, CDCl3) δ 
1H NMR (400 MHz, Chloroform-d) δ 
3.92 (t, J = 5.9 Hz, 1H), 3.65 (d, J = 10.2 Hz, 1H), 2.44 (dd, J = 14.5, 7.6 Hz, 1H), 
2.22 (dtt, J = 11.4, 7.6, 3.4 Hz, 1H), 1.98 (hept, J = 7.0 Hz, 1H), 1.91 – 1.78 (m, 
1H), 1.72 – 1.62 (m, 1H), 1.65 – 1.47 (m, 3H), 1.44 (d, J = 6.9 Hz, 1H), 1.38 – 
1.23 (m, 3H), 1.21 (s, 3H), 1.21 – 1.12 (m, 1H), 1.10 (d, J = 10.5 Hz, 1H), 1.06 (d, J = 6.8 Hz, 6H), 
1.03 – 0.97 (m, 1H), 0.91 (d, J = 6.6 Hz, 3H), 0.85 (d, J = 6.5 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 
85.64 (C), 85.25 (C), 73.34 (CH), 70.74 (CH), 48.78 (CH), 47.96 (CH), 41.91 (CH2), 40.10 (CH2), 
33.70 (CH), 32.20 (CH), 28.70 (CH2), 26.12 (CH2), 25.60 (CH), 24.36 (CH3), 21.67 (CH3), 19.39 
(CH3), 18.39 (CH3), 17.58 (CH3). LRMS (m/z, ESI): 319.22 [M+Na]
+, 261.22, 243.21. HRMS-ESI 
Calculated for C18H32NaO3 [M+Na]
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 Prepared following the same procedure previously used for the preparation of the 19, but using the 





35% yield (unoptimized). Rf = 0.49 (50% EtOAc/hexanes). [α]D
24.4= -73.86 (c 
0.49, CHCl3). 
1H NMR (400 MHz, CDCl3) δ 3.92 (d, J = 5.9 Hz, 1H), 3.67 (d, J = 
10.2 Hz, 1H), 2.45 (dd, J = 14.5, 7.6 Hz, 1H), 2.15 – 2.01 (m, 1H), 1.98 (p, J = 
6.9 Hz, 1H), 1.92 – 1.79 (m, 1H), 1.71 – 1.62 (m, 1H), 1.61 – 1.49 (m, 3H), 1.48 
– 1.41 (m, 1H), 1.41 – 1.22 (m, 11H), 1.22 (s, 3H), 1.18 – 1.10 (m, 1H), 1.06 (d, 
J = 6.9 Hz, 6H), 1.03 – 0.91 (m, 1H), 0.88 (t, J = 6.6 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 85.64 
(C), 85.27 (C), 73.37 (CH), 70.85 (CH), 48.77 (CH), 48.04 (CH), 41.90 (CH2), 36.48 (CH), 32.11 
(CH), 32.08 (CH2), 31.02 (CH2), 29.79 (CH2), 28.85 (CH2), 27.91 (CH2), 26.11 (CH2), 22.82 (CH2), 
19.39 (CH3), 18.39 (CH3), 17.56 (CH3), 14.24 (CH3). LRMS (m/z, ESI): 347.28 [M+Na]
+, 307.26, 
289.25, 282.28. HRMS-ESI Calculated for C20H36NaO3 [M+Na]




A solution of LiEt3BH (1.0M in THF, 849 µL, 0.849 mmol, 7.0 eq.) was added dropwise to a 
solution of 15 (60.0 mg, 0.121 mmol, 1.0 eq.) in THF (750 µL) at 0 °C. The mixture was stirred at 
23 °C for 12 h. After completion of the reaction, water (2 mL) was added and the volatile 
materials were concentrated in vacuo. The aqueous layer was extracted with CH2Cl2 (3× 10 mL) 
and the organic phase was dried over anhydrous Na2SO4, filtered, concentrated in vacuo to 
give a crude residue which was purified by flash chromatography (SiO2, 10 to 60% 
EtOAc/hexanes with 10% CH2Cl2) to afford the corresponding  diol 30 (16.9 mg, 58% yield). 
Rf = 0.26 (50% EtOAc/hexanes). [α]D
23.4= -35.77 (c 0.84 CHCl3). 
1H NMR (400 MHz, CDCl3) δ 3.92 
(td, J = 7.4, 2.5 Hz, 1H), 3.53 – 3.43 (m, 1H), 2.47 (dd, J = 14.5, 7.5 Hz, 1H), 2.03 – 1.90 (m, 2H), 
1.79 – 1.62 (m, 3H), 1.63 – 1.57 (m, 1H), 1.41 – 1.33 (m, 3H), 1.26(dd, J = 6.1, 3.2 Hz, 1H), 1.22 
(s, 3H), 1.19 – 1.09 (m, 2H), 1.06 (d, J = 6.9 Hz, 6H). 13C NMR (101 MHz, CDCl3) δ 85.76 (C), 
85.17 (C), 75.17 (CH), 73.53 (CH), 52.56 (CH), 45.51 (CH), 42.24 (CH2), 31.80 (CH), 28.12 (CH2), 
25.55 (CH2), 21.70 (CH2), 19.25 (CH3), 18.32 (CH3), 17.42 (CH3). LRMS (m/z, ESI): 263.16 









Esterification of diols 27-30:15 
 
(1R,3aR,4S,5R,7R,8S,8aR)-1-butyl-5-(2-hydroxyacetoxy)-7-isopropyl-4-methyldecahydro-4,7-
epoxyazulen-8-yl cinnamate (20): 
52% yield, 3 steps from 27 (unoptimized) Rf = 0.38 (20% 
EtOAc/hexanes). [α]D
19.6= -62.82 (c 1.0 CHCl3). 
1H NMR (400 MHz, CDCl3) 
δ 7.65 (d, J = 16.0 Hz, 1H), 7.57 – 7.47 (m, 2H), 7.45 – 7.34 (m, 3H), 6.39 
(d, J = 16.0 Hz, 1H), 5.26 – 5.13 (m, 2H), 4.19 (d, J = 5.4 Hz, 2H), 2.68 
(dd, J = 14.5, 7.9 Hz, 1H), 2.37 (t, J = 5.5 Hz, 1H), 1.89 (p, J = 6.9 Hz, 2H), 
1.86 – 1.75 (m, 2H), 1.76 – 1.62 (m, 3H), 1.61 – 1.52 (m, 2H), 1.51 – 1.36 
(m, 1H), 1.37 – 1.25 (m, 4H), 1.19 (s, 3H), 1.16 – 1.03 (m, 1H), 1.01 (d, J 
= 6.8 Hz, 3H), 0.97 (d, J = 7.1 Hz, 3H), 0.87 (t, J = 6.9 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 
173.22 (CO), 165.56 (CO), 145.15 (CH), 134.45 (C), 130.53 (CH), 129.05 (CH), 128.26 (CH), 
118.19 (CH), 85.74 (C), 84.71 (C), 76.62 (CH), 71.15 (CH), 60.80 (CH2), 48.48 (CH), 47.40 (CH), 
40.02 (CH2), 37.02 (CH), 33.15 (CH), 29.93 (CH2), 29.47 (CH2), 27.88 (CH2), 24.91 (CH2), 22.88 
(CH2), 19.10 (CH3), 18.36 (CH3), 17.62 (CH3), 14.29 (CH3). LRMS (m/z, ESI): 507.27 [M+Na]
+, 
485.29 [M+H]+,337.24, 261.22. HRMS-ESI Calculated for C29H40NaO6 [M+Na]
+: 507.2717, found 
507.2718. 
(1R,3aR,4S,5R,7R,8S,8aR)-1-isobutyl-5-(2-hydroxyacetoxy)-7-isopropyl-4-methyldecahydro-
4,7-epoxyazulen-8-yl cinnamate (21): 
41% yield, 3 steps from 28 (unoptimized) Rf = 0.30 (20% 
EtOAc/hexanes). [α]D
19.9= -63.94 (c 0.93 CHCl3). 
1H NMR (400 MHz, 
CDCl3) δ 7.64 (d, J = 16.0 Hz, 1H), 7.58 – 7.49 (m, 2H), 7.45 – 7.33 (m, 
3H), 6.39 (d, J = 16.0 Hz, 1H), 5.22 (dd, J = 7.9, 3.0 Hz, 1H), 5.19 (d, J = 
10.2 Hz, 1H), 4.20 (d, J = 5.4 Hz, 2H), 2.67 (dd, J = 14.5, 7.9 Hz, 1H), 2.36 
(t, J = 5.5 Hz, 1H), 2.08 – 1.95 (m, 1H), 1.89 (p, J = 7.0 Hz, 1H), 1.84 – 1.68 
(m, 4H), 1.63 – 1.53 (m, 1H), 1.52 – 1.33 (m, 3H), 1.32 – 1.23 (m, 3H), 
1.19 (s, 3H), 1.02 (d, J = 6.9 Hz, 3H), 0.97 (d, J = 7.0 Hz, 3H), 0.91 (d, J = 6.5 Hz, 2H), 0.77 (d, J = 
6.4 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 173.22 (CO), 165.46 (CO), 145.10 (CH), 134.47 (C), 
130.52 (CH), 129.04 (CH), 128.27 (CH), 118.17 (CH), 85.73 (C), 84.76 (C), 76.63 (CH), 71.08 (CH), 
60.80 (CH2), 48.51 (CH), 47.49 (CH), 40.06 (CH2), 38.88 (CH2), 34.69 (CH), 33.24 (CH), 28.28 
(CH2), 25.83 (CH), 24.82 (CH2), 24.46 (CH3), 21.34 (CH3), 19.10 (CH3), 18.36 (CH3), 17.63 (CH3). 
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 Obtained following the previously described procedures for the preparation of the (-)-englerin A from 
19, but using the corresponding diol 27-30, instead of 19 as starting material. 
S20 
 
LRMS (m/z, ESI): 507.27 [M+Na]+, 485.29 [M+H]+, 372.26, 350.25. HRMS-ESI Calculated for 
C29H41O6 [M+H]
+: 485.2898, found 485.2890. 
 
(1R,3aR,4S,5R,7R,8S,8aR)-1-hexyl-5-(2-hydroxyacetoxy)-7-isopropyl-4-methyldecahydro-4,7-
epoxyazulen-8-yl cinnamate (22): 
58% yield, 3 steps from 29 (unoptimized) Rf = 0.36 (50% 
EtOAc/hexanes). [α]D
22.2= -96.25 (c 0.80 CHCl3). 
1H NMR (300 MHz, 
CDCl3) δ 7.65 (d, J = 16.0 Hz, 1H), 7.59 – 7.47 (m, 2H), 7.48 – 7.32 (m, 
3H), 6.39 (d, J = 16.0 Hz, 1H), 5.25 – 5.14 (m, 2H), 4.19 (d, J = 5.3 Hz, 
2H), 2.67 (dd, J = 14.5, 7.9 Hz, 1H), 2.35 (t, J = 5.5 Hz, 1H), 1.89 (p, J = 
6.9 Hz, 2H), 1.86 – 1.77 (m, 1H), 1.79 – 1.59 (m, 4H), 1.56 (brs, 2H), 
1.50 – 1.38 (m, 1H), 1.37 – 1.20 (m, 8H), 1.19 (s, 3H), 1.15 – 1.05 (m, 
1H), 1.01 (d, J = 6.8 Hz, 3H), 0.97 (d, J = 7.1 Hz, 3H), 0.88 – 0.83 (m, 3H). 13C NMR (75 MHz, 
CDCl3) δ 173.22 (CO), 165.57 (CO), 145.17 (CH), 134.45 (C), 130.53 (CH), 129.05 (CH), 128.26 
(CH), 118.18 (CH), 85.75 (C), 84.71 (C), 76.62 (CH), 71.15 (CH), 60.79 (CH2), 48.48 (CH), 47.39 
(CH), 40.01 (CH2), 37.01 (CH), 33.15 (CH), 32.01 (CH2), 29.71 (CH2), 29.48 (CH2), 27.88 (CH2), 
27.61 (CH2), 24.92 (CH2), 22.82 (CH2), 19.09 (CH3), 18.36 (CH3), 17.62 (CH3), 14.26 (CH3). LRMS 
(m/z, ESI): 536.31 [M+Na]+, 513.32 [M+H]+, 437.31, 381.30, 365.27. HRMS-ESI Calculated for 
C31H45O6 [M+H]
+: 513.3211, found 513.3216. 
(3aR,4S,5R,7R,8S,8aR)-5-(2-hydroxyacetoxy)-7-isopropyl-4-methyldecahydro-4,7-
epoxyazulen-8-yl cinnamate (23):16 
 
18% yield, 3 steps from 30 (unoptimized) Rf = 0.22 (20% EtOAc/hexanes). 
[α]D
24.0= -33.06 (c 0.37 CHCl3). 
1H NMR (400 MHz, CDCl3) δ 7.66 (d, J = 
16.0 Hz, 1H), 7.58 – 7.45 (m, 2H), 7.45 – 7.32 (m, 3H), 6.40 (d, J = 16.0 Hz, 
1H), 5.19 (dd, J = 7.8, 3.0 Hz, 1H), 4.98 (d, J = 9.0 Hz, 1H), 4.20 (d, J = 5.3 
Hz, 2H), 2.67 (dd, J = 14.5, 7.8 Hz, 1H), 2.35 (t, J = 5.5 Hz, 1H), 1.92 (p, J = 
6.9 Hz, 1H), 1.86 – 1.77 (m, 2H), 1.77 – 1.59 (m, 3H), 1.52 (dd, J = 12.3, 
6.5 Hz, 1H), 1.47 – 1.34 (m, 2H), 1.31 – 1.25 (m, 1H), 1.20 (s, 3H), 1.01 (d, 
J = 6.8 Hz, 3H), 0.96 (d, J = 7.1 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 173.21 (CO), 166.08 (CO), 
145.35 (CH), 134.42 (C), 130.57 (CH), 129.06 (CH), 128.27 (CH), 118.04 (CH), 85.57 (C), 84.67 
(C), 76.70 (CH), 74.97 (CH), 60.80 (CH2), 52.42 (CH), 44.43 (CH), 40.58 (CH2), 32.99 (CH), 28.64 
(CH2), 25.14 (CH2), 21.41 (CH2), 18.93 (CH3), 18.39 (CH3), 17.43 (CH3). LRMS (m/z, ESI): 451.21 
[M+Na]+, 429.23 [M+H]+, 381.29, 353.26, 282.28. HRMS-ESI Calculated for C25H32NaO6 
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 Compound 23 is known in its racemic form, see: L. Dong, X. Jiao, X. Liu, C. Tian, J. Asian Nat. Prod. Res., 




octahydro-4,7-epoxyazulen-8-yl cinnamate (24):17 
 
57% yield, (unoptimized). Rf = 0.30 (20% EtOAc/hexanes). [α]D
22.3= -60.60 
(c 0.64 CHCl3). 
1H NMR (300 MHz, CDCl3) δ 7.69 (d, J = 16.0 Hz, 1H), 7.60 – 
7.45 (m, 2H), 7.49 – 7.33 (m, 3H), 6.42 (d, J = 16.0 Hz, 1H), 5.97 (dd, J = 
6.0, 1.8 Hz, 1H), 5.85 – 5.78 (m, 1H), 5.35 (dd, J = 7.7, 2.9 Hz, 1H), 5.04 (d, 
J = 10.3 Hz, 1H), 4.21 (brs, 2H), 2.73 (dd, J = 14.6, 7.7 Hz, 1H), 2.47 – 2.22 
(m, 3H), 2.01 – 1.83 (m, 4H), 1.23 (s, 3H), 1.02 (d, J = 6.8 Hz, 3H), 0.98 (d, J 
= 7.1 Hz, 2H). 13C NMR (75 MHz, CDCl3) δ 173.19 (C), 166.17 (C), 145.58 
(C), 134.38 (C), 133.17 (CH), 131.36 (CH), 130.65 (CH), 129.09 (CH), 128.31 (CH), 117.94 (CH), 
86.27 (C), 83.96 (C), 77.15 (CH), 72.98 (CH), 60.80 (CH2), 54.87 (CH), 48.20 (CH), 40.51 (CH2), 
32.98 (CH), 32.06 (CH2), 18.49 (CH3), 18.43 (CH3), 17.38 (CH3). LRMS (m/z, ESI): 449.19 [M+Na]
+, 
427.21 [M+H]+, 413.31, 351.19, 338.34. HRMS-ESI Calculated for C25H30NaO6 [M+Na]
+: 
449.1935, found 449.1933. 
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 Obtained following the previously described method for the preparation of the (-)-englerin A from 19, 
but using 18 as starting material. 
S22 
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